Durvalumab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2635 publications
First-Line Chemotherapy Regimens for Unresectable Locally Advanced or Metastatic Biliary Tract Cancer: A Systematic Review and Bayesian Network Meta-Analysis.
Journal: JAMA network open
Published: April 15, 2026
New Landscape in the Treatment of Limited-stage Small Cell Lung Cancer: From Conventional Chemoradiotherapy to Latest Advances in Precision Medicine
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: April 14, 2026
Practice-Changing Trials in Gastrointestinal Cancers at ASCO 2025: A Critical Review and Clinical Context.
Journal: Cancer investigation
Published: April 10, 2026
Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.
Journal: Future oncology (London, England)
Published: April 07, 2026
Real-world demographics, clinical characteristics, and testing and treatment patterns in patients with non-small-cell lung cancer and extensive-stage small-cell lung cancer in Belgium: the AIBED study.
Journal: ESMO real world data and digital oncology
Published: April 03, 2026
Body Mass Index and Nutritional Status With Immunotherapy Response in Head and Neck Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: April 02, 2026
National Delphi consensus on perioperative and locally advanced NSCLC management in Colombia.
Journal: Expert review of anticancer therapy
Published: April 01, 2026
CLO26-112: Durvalumab Versus Pembrolizumab With Gemcitabine and Cisplatin in First-Line Treatment of Advanced Biliary Tract Cancer: A Real-World Comparative Effectiveness Analysis.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 20, 2026
Combined Hepatocellular-Cholangiocarcinoma Patient Treated with Durvalumab Plus Gemcitabine and Cisplatin: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
Favorable Response to Chemotherapy with Durvalumab plus Tremelimumab in Two Cases of KRAS G12C-Positive Pulmonary Sarcomatoid Carcinoma: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: March 18, 2026
ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I-III small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 17, 2026
Last Updated: 04/28/2026